Therapies
Read more about Low Dose Naltrexone
About Us
Discover Immune Therapeutics
Find a Doctor
Locate LDN prescribing doctors near you

LDN (low dose naltrexone)

Low Dose Naltrexone as it is known in the United States, or Lodonal as it is known internationally, has its origins in the FDA approved 50mg Naltrexone. Originally used to treat opiate dependences, the Immune Therapeutics patented treatments, which cover a wide range of indications (link to LDN patents), is currently used as an immune modulator.

MENK

OGF/MENK has been shown to halt the growth of the cells and is thought to allow immunological mechanisms (e.g. macrophages, natural killer cells) to accomplish the task of destroying the cancerous cells.

 

 

KRD-Registration-Form

Find A Doctor

 

doctor_locator
0 5 May 2015

Tuesday May 5th Money Info Investment News Radio Show

Airs 10 AM to 11 AM EDT

The show is broadcast live on the internet and on the air from the studios of Radio Station WPSL AM 1590, Port St. Lucie, The Talk of the Treasure Coast

Mrs. Herndon will discuss her work with Immune Therapeutics to combat a variety of chronic, life-threatening diseases.

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system.

The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

Posted in Press Releases, Uncategorized by admin
0 10 March 2015

Ms. Griffin, will be discussing the company’s accomplishments in dynamically effective approaches to combat a variety of chronic, life-threatening diseases. Their novel concepts entail enhancing and refining both the activation and modulation of the body’s natural immune system. The company’s therapies have been demonstrated over time to be highly efficacious and virtually free of side negative effects.

Immune Therapeutics is a specialty pharmaceutical company undergoing a wide range of FDA testing of therapeutic protocols preparatory to the manufacture, commercialization, marketing, and distribution of their patented therapies.

Posted in Press Releases by admin
0 23 January 2015

Orlando, Florida and Dublin, Ireland, January 23, 2015 – Immune Therapeutics, Inc. today announced the signing of the agreement with KRS Global Biotechnology, Inc. for the compounding, packaging and distributing of its naltrexone tablets. The tablets will be compounded for shipment in the United States.

KRS Global is a 503B FDA approved Outsourcing Facility capable of compounding naltrexone tablets in various strengths for individual patients in response to a prescription from a licensed physician.

Posted in Press Releases by admin
Load More